Key result
Dobutamine reduced minimum diastolic pressure from 14 to 10 mm Hg (p<0.01) and accelerated relaxation, while nitroprusside decreased end-diastolic pressure by 7 mm Hg (p<0.01).
Why the study?
Do positive inotropic and vasodilator therapies improve diastolic properties in patients with congestive cardiomyopathy?
Do positive inotropic and vasodilator therapies improve diastolic properties in patients with congestive cardiomyopathy?
p-value: p=<.01
Positive inotropic therapy enhances early diastolic distensibility by accelerating relaxation, whereas vasodilator therapy is more effective in lowering diastolic pressures in congestive cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Supports differential diastolic effects of inotropes versus vasodilators; hypothesis-generating for cardiomyopathy pending randomized trials.
Carroll et al. (1986) studied congestive cardiomyopathy (n=12). Dopamine, dobutamine, and nitroprusside vs. Baseline was evaluated on Diastolic properties (left ventricular pressure decay, minimum diastolic pressure, end-diastolic pressure) (p=<.01). Dobutamine reduced minimum diastolic pressure from 14 to 10 mm Hg (p<0.01) and accelerated relaxation, while nitroprusside decreased end-diastolic pressure by 7 mm Hg (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: